Cargando…
Gut immune cells—A novel therapeutical target for cardiovascular disease?
Despite scientific and clinical advances during the last 50 years cardiovascular disease continues to be the main cause of death worldwide. Especially patients with diabetes display a massive increased cardiovascular risk compared to patients without diabetes. Over the last two decades we have learn...
Autores principales: | Ganesh, Naresh, van der Vorst, Emiel P. C., Spiesshöfer, Jens, He, Shun, Burgmaier, Mathias, Findeisen, Hannes, Lehrke, Michael, Swirski, Filip K., Marx, Nikolaus, Kahles, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421162/ https://www.ncbi.nlm.nih.gov/pubmed/36046186 http://dx.doi.org/10.3389/fcvm.2022.943214 |
Ejemplares similares
-
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
por: Schuett, Katharina Andrea, et al.
Publicado: (2015) -
The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury
por: Kahles, Florian, et al.
Publicado: (2022) -
Coronary microvascular dysfunction as assessed by angiography-derived index of microvascular resistance co-localizes with and may explain the presence of ischemia in stress-cardiac magnetic resonance imaging in the absence of coronary artery disease
por: Milzi, Andrea, et al.
Publicado: (2022) -
Editorial: Emerging roles of miRNAs in cardiovascular disease
por: Santovito, Donato, et al.
Publicado: (2023) -
The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE(−/−) mice by blocking monocyte/macrophage activation
por: Kahles, Florian, et al.
Publicado: (2018)